Pinsent Masons advises Primary Capital Partners on management buy-out of Foster & Freeman

16 Aug 2019 | 09:35 am | 2 min. read

International law firm, Pinsent Masons, has advised Primary Capital Partners on its management buy-out of British engineering company Foster & Freeman.

The Pinsent Masons team advising Primary Capital Partners included Partner Nicole Livesey, Partner Ed Stead, Associate Paul Krivosic and Associate David Meisel.

Primary is a leading provider of private equity finance for UK-based growth companies valued between £20 million and £100 million.

Foster & Freeman are one of the top forensic science equipment suppliers in the world, exporting market-leading, and in many cases unique, products from the UK to more than 160 countries worldwide. The business has a world-class R&D team with a track record in producing industry-leading technology, including the new Recover product which is the only technology available worldwide for developing fingermarks on fired ammunition casings / bomb fragments.

The buy-out continues Primary’s strong track record of investing in high-quality, differentiated niche leaders in specialist manufacturing and industrial products and services.

Nicole Livesey, Partner at Pinsent Masons commented:
"We are proud to have provided legal support to Primary Capital Partners as they now work alongside Foster & Freeman to help them deliver the next phase of growth for the business and invest further in to R&D and new product development to accelerate their technological leadership."

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons appointed to UK Government Trade Law Panel

Multinational law firm Pinsent Masons has been appointed to the UK Government's new Trade Law Panel in an international consortium with BakerHostetler in the USA, and Fasken in Canada, to advise on international trade law disputes.

Pinsent Masons advises on Sustainability Bond issued by Aster Group

Multinational law firm Pinsent Masons has advised the joint lead managers in relation to a £250m sustainability bond issued by Aster Group to develop new affordable homes.

Pinsent Masons advises on 5G Create - the £28m government funded 5G test projects

Multinational law firm Pinsent Masons has advised the Department for Digital, Culture, Media and Sport (DCMS) on its innovative joint £28m investment in 5G test projects to showcase the capability of 5G technology across a range of industries and identify commercially sustainable long-term use cases.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts